Literature DB >> 16800620

Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase.

Heather A Gennadios1, Douglas A Whittington, Xuechen Li, Carol A Fierke, David W Christianson.   

Abstract

The metal-dependent deacetylase LpxC catalyzes the first committed step of lipid A biosynthesis in Gram-negative bacteria. Accordingly, LpxC is an attractive target for the development of inhibitors that may serve as potential new antibiotics for the treatment of Gram-negative bacterial infections. Here, we report the 2.7 A resolution X-ray crystal structure of LpxC complexed with the substrate analogue inhibitor TU-514 and the 2.0 A resolution structure of LpxC complexed with imidazole. The X-ray crystal structure of LpxC complexed with TU-514 allows for a detailed examination of the coordination geometry of the catalytic zinc ion and other enzyme-inhibitor interactions in the active site. The hydroxamate group of TU-514 forms a bidentate chelate complex with the zinc ion and makes hydrogen bond interactions with conserved active site residues E78, H265, and T191. The inhibitor C-4 hydroxyl group makes direct hydrogen bond interactions with E197 and H58. Finally, the C-3 myristate moiety of the inhibitor binds in the hydrophobic tunnel of the active site. These intermolecular interactions provide a foundation for understanding structural aspects of enzyme-substrate and enzyme-inhibitor affinity. Comparison of the TU-514 complex with cacodylate and imidazole complexes suggests a possible substrate diphosphate binding site and highlights residues that may stabilize the tetrahedral intermediate and its flanking transition states in catalysis. Evidence of a catalytic zinc ion in the native zinc enzyme coordinated by H79, H238, D242, and two water molecules with square pyramidal geometry is also presented. These results suggest that the native state of this metallohydrolase may contain a pentacoordinate zinc ion, which contrasts with the native states of archetypical zinc hydrolases such as thermolysin and carboxypeptidase A.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800620      PMCID: PMC2505344          DOI: 10.1021/bi060823m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

2.  Structure and metal-dependent mechanism of peptidoglycan deacetylase, a streptococcal virulence factor.

Authors:  David E Blair; Alexander W Schüttelkopf; James I MacRae; Daan M F van Aalten
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-12       Impact factor: 11.205

3.  SHELXL: high-resolution refinement.

Authors:  G M Sheldrick; T R Schneider
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities.

Authors:  R M Esnouf
Journal:  J Mol Graph Model       Date:  1997-04       Impact factor: 2.518

Review 5.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

6.  Antibacterial agents that inhibit lipid A biosynthesis.

Authors:  H R Onishi; B A Pelak; L S Gerckens; L L Silver; F M Kahan; M H Chen; A A Patchett; S M Galloway; S A Hyland; M S Anderson; C R Raetz
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

7.  Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine: insights into the mechanism and inhibitor design.

Authors:  Brian E Coggins; Amanda L McClerren; Ling Jiang; Xuechen Li; Johannes Rudolph; Ole Hindsgaul; Christian R H Raetz; Pei Zhou
Journal:  Biochemistry       Date:  2005-02-01       Impact factor: 3.162

8.  Kinetic analysis of the zinc-dependent deacetylase in the lipid A biosynthetic pathway.

Authors:  Amanda L McClerren; Pei Zhou; Ziqiang Guan; Christian R H Raetz; Johannes Rudolph
Journal:  Biochemistry       Date:  2005-02-01       Impact factor: 3.162

9.  UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme.

Authors:  J E Jackman; C R Raetz; C A Fierke
Journal:  Biochemistry       Date:  1999-02-09       Impact factor: 3.162

10.  Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria.

Authors:  M Vaara
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

View more
  21 in total

1.  4D-LQTA-QSAR and docking study on potent Gram-negative specific LpxC inhibitors: a comparison to CoMFA modeling.

Authors:  Jahan B Ghasemi; Reihaneh Safavi-Sohi; Euzébio G Barbosa
Journal:  Mol Divers       Date:  2011-11-30       Impact factor: 2.943

2.  Structure of the metal-dependent deacetylase LpxC from Yersinia enterocolitica complexed with the potent inhibitor CHIR-090 .

Authors:  Kathryn E Cole; Samuel G Gattis; Heather D Angell; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2010-12-20       Impact factor: 3.162

3.  Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.

Authors:  Igor Mochalkin; John D Knafels; Sandra Lightle
Journal:  Protein Sci       Date:  2008-03       Impact factor: 6.725

4.  Binding of uridine 5'-diphosphate in the "basic patch" of the zinc deacetylase LpxC and implications for substrate binding.

Authors:  Heather A Gennadios; David W Christianson
Journal:  Biochemistry       Date:  2006-11-30       Impact factor: 3.162

5.  Structural basis of the promiscuous inhibitor susceptibility of Escherichia coli LpxC.

Authors:  Chul-Jin Lee; Xiaofei Liang; Ramesh Gopalaswamy; Javaria Najeeb; Eugene D Ark; Eric J Toone; Pei Zhou
Journal:  ACS Chem Biol       Date:  2013-10-31       Impact factor: 5.100

6.  Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.

Authors:  Kerry E Murphy-Benenato; Nelson Olivier; Allison Choy; Philip L Ross; Matthew D Miller; Jason Thresher; Ning Gao; Michael R Hale
Journal:  ACS Med Chem Lett       Date:  2014-09-23       Impact factor: 4.345

7.  Translating slow-binding inhibition kinetics into cellular and in vivo effects.

Authors:  Grant K Walkup; Zhiping You; Philip L Ross; Eleanor K H Allen; Fereidoon Daryaee; Michael R Hale; John O'Donnell; David E Ehmann; Virna J A Schuck; Ed T Buurman; Allison L Choy; Laurel Hajec; Kerry Murphy-Benenato; Valerie Marone; Sara A Patey; Lena A Grosser; Michele Johnstone; Stephen G Walker; Peter J Tonge; Stewart L Fisher
Journal:  Nat Chem Biol       Date:  2015-04-20       Impact factor: 15.040

Review 8.  Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis.

Authors:  Adam W Barb; Pei Zhou
Journal:  Curr Pharm Biotechnol       Date:  2008-02       Impact factor: 2.837

9.  Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.

Authors:  Daniel P Dowling; Stephanie L Gantt; Samuel G Gattis; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

10.  Residue ionization in LpxC directly observed by 67Zn NMR spectroscopy.

Authors:  Andrew S Lipton; Robert W Heck; Marcy Hernick; Carol A Fierke; Paul D Ellis
Journal:  J Am Chem Soc       Date:  2008-08-30       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.